by GI Research Foundation | Feb 19, 2024 | GIRF in the News, Research and Discovery
Backed by $5.4 million in grants from the GI Research Foundation, prospective cancer vaccines developed by Elicio Therapeutics show strong T-cell activation in animal trials. And similar vaccines from Elicio are already in human trials. CHICAGO, February 19, 2024, GI...